Bausch + Lomb ULTRA Contact Lenses Get FDA Approval For Extended Wear Indication

(RTTNews) - Bausch + Lomb, eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International (VRX, VRX.TO), said that the U.S. Food and Drug Administration has approved the Bausch + Lomb ULTRA family of contact lenses for extended wear of up to six nights and seven days of continuous wear.

Bausch + Lomb ULTRA contact lenses are engineered to provide all-day comfort and consistently clear vision. The family of contact lenses features polyvinylpyrrolidone (PVP) for enhanced wettability, a high oxygen transmissibility level (Dk/t) (i.e. ability of the lens to let oxygen reach the eye), and a low modulus (i.e. the degree of a contact lens material's flexibility or its resistance to being deformed).

The company noted that Bausch + Lomb ULTRA contact lenses are also available for patients with astigmatism and presbyopia.